2018 ASCO-SITC Clinical Immuno-Oncology Symposium Public

Abstract 174, "Treatment with PD-1 inhibitors in NSCLC beyond disease progression: Impact on symptoms and cost," presented by Mor Tal Moskovitz, MD, during Poster Session B

San Francisco, CA - 2018 Clinical Immuno-Oncology Symposium – Abstract 174, "Treatment with PD-1 inhibitors in NSCLC beyond disease progression: Impact on symptoms and cost," presented by Mor Tal Moskovitz, MD, during Poster Session B at the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium here today, Friday, Jan. 26, 2018. The conference, which is a collaboration between the American Society of Clinical Oncology and Society for Immunotherapy of Cancer, is focused on clinical and translational research in immuno-oncology and the implications for clinical care. Photo by © ASCO/Scott Morgan 2018.